Published in Blood Weekly, April 24th, 2003
Their findings were presented at the American Academy of Neurology Annual Meeting in Honolulu.
With no known cure, ALS patients gradually become totally paralyzed, while most retain complete cognitive function, with an average life expectancy of 2-5 years after diagnosis.
Only recently has a pharmacological therapy been shown to slow the progression of ALS, with modest effects. Nothing has demonstrated improvement in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.